代谢功能障碍相关脂肪性肝病中高敏肌钙蛋白与全因及病因特异性死亡率的关联
基于美国国家健康与营养调查1999-2004并随访至2019年的数据,在无心血管疾病的MASLD人群中,高敏肌钙蛋白T每升高1个标准差,全因死亡风险增加29%(HR 1.29,95%CI 1.16-1.44),心血管死亡风险增加44%(HR 1.44,95%CI 1.20-1.72),与癌症死亡无显著关联。
要点
- MASLD且无心血管疾病者中,高敏肌钙蛋白T升高与全因及心血管死亡风险递增相关。
- 高敏肌钙蛋白T每升高1个标准差,全因死亡HR 1.29(95%CI 1.16-1.44),心血管死亡HR 1.44(95%CI 1.20-1.72)。
- 高敏肌钙蛋白I的3种检测方法与心血管死亡也呈显著关联,与癌症死亡无显著关联。
核心结论
- 在无心血管疾病的MASLD人群中筛查高敏肌钙蛋白T或I可识别未来全因死亡风险较高的亚群,主要归因于心血管疾病相关死亡。
研究设计与样本
- 使用美国国家健康与营养调查1999-2004年数据,并将死亡率数据集链接至2019年,采用Cox回归模型评估MASLD且无心血管疾病个体中高敏肌钙蛋白与全因及病因特异性死亡率的关联。
主要发现
- 中位随访17.5年(IQR 15.9-19.1)期间,MASLD患者中较高水平的高敏肌钙蛋白T与全因和心血管死亡率风险递增相关,调整人口学、临床、生活方式和代谢危险因素后仍显著。
- 高敏肌钙蛋白T每升高1个标准差,全因死亡率增加29%(HR 1.29,95%CI 1.16-1.44),心血管死亡率增加44%(HR 1.44,95%CI 1.20-1.72)。
- 3种高敏肌钙蛋白I检测方法均显示高敏肌钙蛋白与心血管死亡呈显著关联(趋势P值),与高敏肌钙蛋白T类似。
- 高敏肌钙蛋白与癌症相关死亡率无显著关联。
临床怎么用
- 作者认为,在无心血管疾病的MASLD个体中筛查高敏肌钙蛋白T或I可识别未来全因死亡风险较高、主要由心血管疾病相关死亡驱动的亚群。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Characterising the phenotypic features of individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) can help identify high-risk subpopulations within this group. High-sensitivity troponin (hs-troponin) is a significant risk factor for future cardiovascular disease events. AIMS: We studied the association of hs-troponin in the absence of cardiovascular disease with all-cause and cause-specific mortality among individuals with MASLD. METHODS: We used the National Health and Nutrition Examination Survey 1999-2004 and linked the mortality dataset through 2019. We used Cox regression models to assess the association between hs-troponin with all-cause and cause-specific mortality among individuals with MASLD and without cardiovascular disease. RESULTS: During the median follow-up period of 17.5 years (IQR: 15.9-19.1), higher levels of hs-troponin T among individuals with MASLD were associated with progressively higher hazards of all-cause and cardiovascular mortality, which remained significant after adjustment for demographic, clinical, lifestyle and metabolic risk factors. There was a 29% (hazard ratio [HR]: 1.29, 95% confidence interval [CI]: 1.16-1.44) increase in all-cause mortality and a 44% (HR: 1.44, 95% CI: 1.20-1.72) increase in cardiovascular mortality for every rise in 1-standard deviation of hs-troponin T. A significant association between hs-troponin (p for trend) and cardiovascular mortality was noted with 3 hs-troponin I assays, similar to hs-troponin T. There was no significant association between hs-troponin and cancer-related mortality. CONCLUSION: Screening hs-troponin T or I in individuals with MASLD can identify at-risk subpopulations within this group that have a higher risk for future all-cause mortality, predominantly due to cardiovascular disease-related mortality in the population without cardiovascular disease.
引用
- Kim D, Danpanichkul P, Wijarnpreecha K, et al. Association of High-Sensitivity Troponins in Metabolic Dysfunction-Associated Steatotic Liver Disease With All-Cause and Cause-Specific Mortality. Aliment Pharmacol Ther. 2025. PMID: 40166918. doi:10.1111/apt.70128
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。